SLSN
SOLESENCE, INC.
Company overview
- Market capitalization
- $58.78M
- Employees
- 115
- Latest publication
- 2026-09-29
About SOLESENCE, INC.
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 15,332,000USD | 12,957,000USD | 12,483,000USD | 14,597,000USD | 20,359,000USD | 14,625,000USD | 12,567,000USD | 16,866,000USD |
| Cost Of Revenue | 10,584,000USD | 9,630,000USD | 9,057,000USD | 11,227,000USD | 14,482,000USD | 11,243,000USD | 9,801,000USD | 10,764,000USD |
| Gross Profit | 4,748,000USD | 3,327,000USD | 3,426,000USD | 3,370,000USD | 5,877,000USD | 3,382,000USD | 2,766,000USD | 6,102,000USD |
| Research Development | 947,000USD | 1,038,000USD | 1,032,000USD | 1,082,000USD | 955,000USD | 1,018,000USD | 1,091,000USD | 970,000USD |
| Selling General Administrative | 3,680,000USD | 2,799,000USD | 2,213,000USD | 3,069,000USD | 3,012,000USD | 2,108,000USD | 1,898,000USD | 1,934,000USD |
| Total Operating Expenses | 4,627,000USD | 3,831,000USD | 3,240,000USD | 4,151,000USD | 3,967,000USD | 3,126,000USD | 2,989,000USD | 2,904,000USD |
| Operating Income | 121,000USD | -504,000USD | 186,000USD | -781,000USD | 1,910,000USD | 256,000USD | -223,000USD | 3,198,000USD |
| Total Other Income Expense Net | -279,000USD | -262,000USD | -340,000USD | -339,000USD | 1,147,000USD | -176,000USD | -108,000USD | -153,000USD |
| Income Before Tax | -158,000USD | -766,000USD | -154,000USD | -1,120,000USD | 3,057,000USD | 80,000USD | -331,000USD | 3,045,000USD |
| Income Tax Expense | 0USD | — | -317,000USD | — | 390,000USD | — | 227,000USD | — |
| Net Income | -158,000USD | -766,000USD | 163,000USD | -1,120,000USD | 2,667,000USD | 80,000USD | -558,000USD | 3,045,000USD |
| Interest Expense | — | 263,000USD | 328,000USD | 339,000USD | 87,000USD | 176,000USD | 108,000USD | 153,000USD |
| Net Interest Income | — | -263,000USD | -328,000USD | -339,000USD | -87,000USD | -176,000USD | -108,000USD | -153,000USD |
| Tax Provision | — | 0USD | -317,000USD | 0USD | 390,000USD | 0USD | 227,000USD | 0USD |
| Net Income From Continuing Ops | — | -766,000USD | 163,000USD | -1,120,000USD | 2,667,000USD | 80,000USD | -558,000USD | 3,045,000USD |
| Ebit | — | -503,000USD | 174,000USD | -781,000USD | 3,144,000USD | 256,000USD | -223,000USD | 3,198,000USD |
| Ebitda | — | -191,000USD | 394,000USD | -556,000USD | 3,369,000USD | 482,000USD | 5,000USD | 3,429,000USD |
| Depreciation And Amortization | — | 312,000USD | 220,000USD | 225,000USD | 225,000USD | 226,000USD | 228,000USD | 231,000USD |
| Reconciled Depreciation | — | 313,000USD | 221,000USD | 225,000USD | 225,000USD | 226,000USD | 228,000USD | 231,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|
| Total Revenue | 62,064,000USD | 52,347,000USD | 29,475,000USD |
| Cost Of Revenue | 46,037,000USD | 36,159,000USD | 20,785,000USD |
| Gross Profit | 16,027,000USD | 16,188,000USD | 8,690,000USD |
| Research Development | 4,075,999USD | 3,837,000USD | 2,235,000USD |
| Selling General Administrative | 10,401,000USD | 7,219,000USD | 3,896,000USD |
| Total Operating Expenses | 14,455,000USD | 11,056,000USD | 6,131,000USD |
| Operating Income | 1,572,000USD | 5,132,000USD | 2,559,000USD |
| Interest Expense | 931,000USD | 670,000USD | 1,154,000USD |
| Net Interest Income | -931,000USD | -670,000USD | -1,154,000USD |
| Income Before Tax | 1,863,000USD | 4,462,000USD | 2,357,000USD |
| Income Tax Expense | 73,000USD | 227,000USD | 37,000USD |
| Tax Provision | 73,000USD | 227,000USD | 37,000USD |
| Net Income | 1,790,000USD | 4,235,000USD | 2,320,000USD |
| Net Income From Continuing Ops | 1,790,000USD | 4,235,000USD | 2,320,000USD |
| Ebit | 2,794,000USD | 5,132,000USD | 3,511,000USD |
| Ebitda | 3,691,000USD | 6,060,000USD | 3,965,000USD |
| Depreciation And Amortization | 897,000USD | 928,000USD | 454,000USD |
| Reconciled Depreciation | 897,000USD | 928,000USD | 454,000USD |
| Total Other Income Expense Net | 291,000USD | -670,000USD | -202,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 46,437,000USD | 47,794,000USD | 50,055,000USD | 53,987,000USD | 59,956,000USD | 57,016,000USD | 50,002,000USD | 48,047,000USD |
| Cash And Equivalents | 1,046,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 25,270,000USD | 26,413,000USD | 28,776,000USD | 32,792,000USD | 38,770,000USD | 35,904,000USD | 29,348,000USD | 29,761,000USD |
| Other Current Assets | 1,922,000USD | 1,902,000USD | 2,141,000USD | 3,785,000USD | 3,781,000USD | 3,090,000USD | 2,803,000USD | 3,061,000USD |
| Other Non Current Assets | 36,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 33,283,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 26,013,000USD | 12,691,000USD | 13,929,000USD | 17,864,000USD | 22,536,000USD | 32,876,000USD | 25,773,000USD | 23,288,000USD |
| Other Current Liabilities | 3,478,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 13,154,000USD | 16,967,000USD | 17,634,000USD | 17,227,000USD | 18,188,000USD | 15,156,000USD | 14,946,000USD | 15,169,000USD |
| Total Equity Including Noncontrolling Interest | 13,154,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 1,937,000USD | — | — | — | — | — | — | — |
| Net Receivables | 9,345,000USD | 6,379,000USD | 6,836,000USD | 9,709,000USD | 11,049,000USD | 9,085,000USD | 4,869,000USD | 8,732,000USD |
| Inventory | 12,957,000USD | 17,559,000USD | 18,511,000USD | 18,869,000USD | 19,832,000USD | 21,912,000USD | 20,267,000USD | 15,043,000USD |
| Property Plant Equipment Net | 21,131,000USD | 21,344,000USD | 6,913,000USD | 21,195,000USD | 21,186,000USD | 21,111,000USD | 20,651,000USD | 18,284,000USD |
| Accounts Payable | 4,968,000USD | 4,672,000USD | 4,390,000USD | 4,826,000USD | 6,891,000USD | 9,168,000USD | 10,690,000USD | 6,562,000USD |
| Short Term Debt | 1,343,000USD | 4,343,000USD | 6,022,000USD | 6,540,000USD | 7,330,000USD | 13,820,000USD | 6,260,000USD | 7,291,000USD |
| Common Stock | 706,000USD | 706,000USD | 706,000USD | 705,000USD | 704,000USD | 700,000USD | 700,000USD | 699,000USD |
| Retained Earnings | -103,306,000USD | -99,404,000USD | -98,638,000USD | -98,801,000USD | -97,681,000USD | -100,348,000USD | -100,428,000USD | -99,869,000USD |
| Total Liab | — | 30,827,000USD | 32,421,000USD | 36,760,000USD | 41,768,000USD | 41,860,000USD | 35,056,000USD | 32,878,000USD |
| Other Current Liab | — | 2,511,000USD | 2,587,000USD | 6,498,000USD | 6,146,000USD | 5,266,000USD | 3,252,000USD | 3,207,000USD |
| Capital Stock | — | 706,000USD | 706,000USD | 705,000USD | 704,000USD | 700,000USD | 700,000USD | 699,000USD |
| Other Assets | — | 1USD | — | — | — | — | — | — |
| Cash | — | 573,000USD | 1,288,000USD | 429,000USD | 4,108,000USD | 1,817,000USD | 1,409,000USD | 2,925,000USD |
| Cash And Short Term Investments | — | 573,000USD | 1,288,000USD | 429,000USD | 4,108,000USD | 1,817,000USD | 1,409,000USD | 2,925,000USD |
| Current Deferred Revenue | — | 1,165,000USD | 930,000USD | 1,197,000USD | 2,169,000USD | 4,622,000USD | 5,571,000USD | 6,228,000USD |
| Net Debt | — | 21,710,000USD | 23,032,000USD | 24,755,000USD | 22,204,000USD | 20,739,000USD | 13,888,000USD | 13,712,000USD |
| Short Long Term Debt | — | 3,047,000USD | 4,767,000USD | 5,316,000USD | 6,099,000USD | 12,492,000USD | 5,000,000USD | 6,200,000USD |
| Short Long Term Debt Total | — | 22,283,000USD | 24,320,000USD | 25,184,000USD | 26,312,000USD | 22,556,000USD | 15,297,000USD | 16,637,000USD |
| Long Term Debt | — | 10,500,000USD | 10,500,000USD | 10,500,000USD | 10,500,000USD | — | — | — |
| Property Plant Equipment Gross | — | 21,344,000USD | 44,945,000USD | 21,195,000USD | 21,186,000USD | 21,111,000USD | 43,467,000USD | 18,284,000USD |
| Common Stock Shares Outstanding | — | 70,625,494shares | 72,808,204shares | 70,500,925shares | 72,497,829shares | 72,632,116shares | 70,011,564shares | 71,935,394shares |
| Non Current Assets Total | — | 21,380,999USD | 21,279,000USD | 21,195,000USD | 21,186,000USD | 21,112,000USD | 20,654,000USD | 18,286,000USD |
| Non Current Liabilities Total | — | 18,136,000USD | 18,492,000USD | 18,896,000USD | 19,232,000USD | 8,984,000USD | 9,283,000USD | 9,590,000USD |
| Non Currrent Assets Other | — | 36,999USD | 14,366,000USD | 13,938,000USD | 13,559,000USD | 1,000USD | 3,000USD | 2,000USD |
| Net Working Capital | — | 13,722,000USD | 14,847,000USD | 14,928,000USD | 16,234,000USD | 3,028,000USD | 3,575,000USD | 6,473,000USD |
| Unclassified Current Liabilities | — | -3,047,000USD | -4,767,000USD | -6,513,000USD | -6,099,000USD | -12,492,000USD | -5,000,000USD | -6,200,000USD |
| Unclassified Non Current Liabilities | — | 7,636,000USD | 7,992,000USD | 8,396,000USD | 8,732,000USD | 8,984,000USD | 9,283,000USD | 9,590,000USD |
| Unclassified Equity | — | 114,959,000USD | 114,860,000USD | 114,618,000USD | 114,461,000USD | 114,104,000USD | 113,974,000USD | 113,640,000USD |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | — | — | — | — |
| Unclassified Non Current Assets | — | — | — | -13,938,000USD | -13,559,000USD | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Assets | 50,055,000USD | 50,002,000USD | 32,881,000USD | 33,558,000USD | 28,394,000USD |
| Other Current Assets | 2,141,000USD | 2,803,000USD | 1,082,000USD | 866,000USD | 910,000USD |
| Total Liab | 32,421,000USD | 35,056,000USD | 30,979,000USD | 27,909,000USD | 20,929,000USD |
| Total Stockholder Equity | 17,634,000USD | 14,946,000USD | 1,902,000USD | 5,649,000USD | 7,465,000USD |
| Other Current Liab | 2,587,000USD | 3,252,000USD | 741,000USD | 559,000USD | 504,000USD |
| Common Stock | 706,000USD | 700,000USD | 496,000USD | 493,000USD | 489,000USD |
| Capital Stock | 706,000USD | 700,000USD | 496,000USD | 493,000USD | 489,000USD |
| Retained Earnings | -98,638,000USD | -100,428,000USD | -104,663,000USD | -100,070,000USD | -97,447,000USD |
| Cash | 1,288,000USD | 1,409,000USD | 1,722,000USD | 2,186,000USD | 657,000USD |
| Cash And Short Term Investments | 1,288,000USD | 1,409,000USD | 1,722,000USD | 2,186,000USD | 657,000USD |
| Total Current Assets | 28,776,000USD | 29,348,000USD | 16,302,000USD | 16,625,000USD | 11,599,000USD |
| Total Current Liabilities | 13,929,000USD | 25,773,000USD | 15,589,000USD | 13,835,000USD | 7,340,000USD |
| Current Deferred Revenue | 930,000USD | 5,571,000USD | 2,353,000USD | 2,228,000USD | 905,000USD |
| Net Debt | 23,032,000USD | 13,888,000USD | 19,537,000USD | 15,919,000USD | 14,094,000USD |
| Short Term Debt | 6,022,000USD | 6,260,000USD | 6,107,000USD | 4,282,000USD | 2,045,000USD |
| Short Long Term Debt | 4,767,000USD | 5,000,000USD | 4,810,000USD | 4,282,000USD | 1,351,000USD |
| Short Long Term Debt Total | 24,320,000USD | 15,297,000USD | 21,259,000USD | 18,105,000USD | 14,751,000USD |
| Long Term Debt | 10,500,000USD | — | 6,000,000USD | 4,000,000USD | 1,000,000USD |
| Net Receivables | 6,836,000USD | 4,869,000USD | 3,467,000USD | 4,734,000USD | 3,937,000USD |
| Inventory | 18,511,000USD | 20,267,000USD | 10,031,000USD | 8,839,000USD | 6,095,000USD |
| Accounts Payable | 4,390,000USD | 10,690,000USD | 6,388,000USD | 6,766,000USD | 3,886,000USD |
| Property Plant Equipment Net | 6,913,000USD | 20,651,000USD | 16,575,000USD | 16,927,000USD | 16,787,000USD |
| Property Plant Equipment Gross | 44,945,000USD | 43,467,000USD | 38,474,000USD | 38,093,000USD | 37,397,000USD |
| Common Stock Shares Outstanding | 72,579,715shares | 65,028,815shares | 49,556,305shares | 49,117,000shares | 47,039,173shares |
| Non Current Assets Total | 21,279,000USD | 20,654,000USD | 16,579,000USD | 16,933,000USD | 16,795,000USD |
| Non Current Liabilities Total | 18,492,000USD | 9,283,000USD | 15,390,000USD | 14,074,000USD | 13,589,000USD |
| Non Currrent Assets Other | 14,366,000USD | 3,000USD | 4,000USD | 6,000USD | 8,000USD |
| Net Working Capital | 14,847,000USD | 3,575,000USD | 713,000USD | 2,790,000USD | 4,259,000USD |
| Unclassified Current Liabilities | -4,767,000USD | -5,000,000USD | -4,810,000USD | -4,282,000USD | -1,351,000USD |
| Unclassified Non Current Liabilities | 7,992,000USD | 9,283,000USD | 9,390,000USD | 10,074,000USD | 12,589,000USD |
| Unclassified Equity | 114,860,000USD | 113,974,000USD | 105,573,000USD | 104,733,000USD | 103,934,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 636,000USD |
| Stock Based Compensation | 162,000USD |
| Change To Account Receivables | -2,509,000USD |
| Change To Inventory | 2,006,000USD |
| Change To Liabilities | 1,371,000USD |
| Change In Working Capital | 1,489,000USD |
| Operating Cash Flow | 1,708,000USD |
| Investing Cash Flow | -997,000USD |
| Financing Cash Flow | -953,000USD |
| Change In Cash | -242,000USD |
| End Cash Flow | 1,046,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -766,000USD | 163,000USD | -1,120,000USD | 2,667,000USD | 80,000USD | -558,000USD | 3,046,000USD | 854,000USD |
| Depreciation | 313,000USD | 221,000USD | 225,000USD | 225,000USD | 226,000USD | 228,000USD | 231,000USD | 235,000USD |
| Stock Based Compensation | 83,000USD | 206,000USD | 122,000USD | 120,000USD | 127,000USD | 248,000USD | 160,000USD | 157,000USD |
| Other Non Cash Items | 83,000USD | 12,549,000USD | -13,058,000USD | — | — | — | — | — |
| Change To Account Receivables | 457,000USD | 2,873,000USD | 1,340,000USD | -1,964,000USD | -4,216,000USD | 3,863,000USD | -2,800,000USD | -650,000USD |
| Change To Inventory | 952,000USD | 358,000USD | 963,000USD | 2,080,000USD | -1,645,000USD | -5,224,000USD | -1,169,000USD | -593,000USD |
| Change In Working Capital | 1,887,000USD | 1,229,000USD | -1,738,000USD | -3,666,000USD | -7,654,000USD | 2,271,000USD | 765,000USD | -1,811,000USD |
| Total Cash From Operating Activities | 1,517,000USD | 1,819,000USD | -2,511,000USD | -654,000USD | -7,221,000USD | 2,189,000USD | 4,202,000USD | -565,000USD |
| Capital Expenditures | -528,000USD | -1,408,000USD | -418,000USD | -1,275,000USD | 0USD | -2,593,000USD | -1,403,000USD | -477,000USD |
| Free Cash Flow | 989,000USD | 411,000USD | -2,929,000USD | -1,929,000USD | -7,221,000USD | -404,000USD | 2,799,000USD | -1,042,000USD |
| Total Cashflows From Investing Activities | -528,000USD | -450,000USD | -418,000USD | -1,408,000USD | 133,000USD | -2,593,000USD | -1,403,000USD | -477,000USD |
| Net Borrowings | -1,720,000USD | -547,000USD | -786,000USD | 4,107,000USD | 7,492,000USD | -1,200,000USD | -2,271,000USD | — |
| Total Cash From Financing Activities | -1,704,000USD | -510,000USD | -750,000USD | 4,353,000USD | 7,496,000USD | -1,112,000USD | -2,232,000USD | 1,382,000USD |
| Change In Cash | -715,000USD | 859,000USD | -3,679,000USD | 2,291,000USD | 408,000USD | -1,516,000USD | 567,000USD | 340,000USD |
| Begin Period Cash Flow | 1,288,000USD | 429,000USD | 4,108,000USD | 1,817,000USD | 1,409,000USD | 2,925,000USD | 2,358,000USD | 2,018,000USD |
| End Period Cash Flow | 573,000USD | 1,288,000USD | 429,000USD | 4,108,000USD | 1,817,000USD | 1,409,000USD | 2,925,000USD | 2,358,000USD |
| Issuance Of Capital Stock | — | -286,000USD | 286,000USD | 0USD | 0USD | -1,996,000USD | 1,996,000USD | 0USD |
| Other Cashflows From Investing Activities | — | 958,000USD | -1,826,000USD | — | 133,000USD | — | — | — |
| Other Cashflows From Financing Activities | — | 37,000USD | 36,000USD | 246,000USD | 4,000USD | 88,000USD | 39,000USD | -39,000USD |
| Unclassified Operating Cash Flow | — | -12,549,000USD | 13,058,000USD | — | — | — | — | — |
| Investments | — | — | -418,000USD | -1,408,000USD | 133,000USD | -2,593,000USD | -1,403,000USD | -477,000USD |
| Unclassified Investing Cash Flow | — | — | 2,244,000USD | 1,275,000USD | — | 2,593,000USD | 1,403,000USD | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | 1,996,000USD | -1,996,000USD | 1,421,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20072007-12-31 · USD | FY 20062006-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | 1,790,000USD | 4,235,000USD | -4,390,000USD | -2,623,000USD | 2,320,000USD | -3,591,000USD | -5,178,000USD |
| Depreciation | 897,000USD | 928,000USD | 742,000USD | 567,000USD | 454,000USD | — | — |
| Stock Based Compensation | 575,000USD | 725,000USD | 773,000USD | 625,000USD | 160,000USD | — | — |
| Other Non Cash Items | -11,829,000USD | — | — | 2,570,000USD | -49,000USD | — | — |
| Change To Account Receivables | -1,967,000USD | -1,402,000USD | 1,064,000USD | -797,000USD | -1,005,000USD | — | — |
| Change To Inventory | 1,756,000USD | -10,236,000USD | -1,192,000USD | -2,744,000USD | -1,755,000USD | — | — |
| Change In Working Capital | -11,829,000USD | -3,917,000USD | 869,000USD | -2,789,000USD | -564,000USD | — | — |
| Total Cash From Operating Activities | -8,567,000USD | 1,971,000USD | -2,006,000USD | -1,650,000USD | 2,321,000USD | — | — |
| Capital Expenditures | -2,143,000USD | -4,558,000USD | -1,051,000USD | -2,823,000USD | -1,874,000USD | 0USD | 0USD |
| Free Cash Flow | -10,710,000USD | -2,587,000USD | -3,057,000USD | -4,473,000USD | 447,000USD | — | — |
| Total Cashflows From Investing Activities | -2,143,000USD | -4,558,000USD | -1,051,000USD | -2,823,000USD | -1,874,000USD | — | — |
| Net Borrowings | 10,266,000USD | -5,810,000USD | 2,520,000USD | 5,820,000USD | -981,000USD | — | — |
| Total Cash From Financing Activities | 10,589,000USD | 2,274,000USD | 2,593,000USD | 6,002,000USD | -747,000USD | — | — |
| Issuance Of Capital Stock | 0USD | 6,000,000USD | 0USD | — | — | — | — |
| Change In Cash | -121,000USD | -313,000USD | -464,000USD | 1,529,000USD | -300,000USD | — | — |
| Begin Period Cash Flow | 1,409,000USD | 1,722,000USD | 2,186,000USD | 657,000USD | 957,000USD | — | — |
| End Period Cash Flow | 1,288,000USD | 1,409,000USD | 1,722,000USD | 2,186,000USD | 657,000USD | 957,000USD | — |
| Other Cashflows From Investing Activities | -2,143,000USD | -4,558,000USD | — | — | — | — | — |
| Other Cashflows From Financing Activities | 10,589,000USD | 8,084,000USD | 73,000USD | 6,113,000USD | 234,000USD | — | — |
| Unclassified Operating Cash Flow | 11,829,000USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | 2,143,000USD | 9,116,000USD | 1,051,000USD | 2,823,000USD | 1,874,000USD | — | — |
| Unclassified Financing Cash Flow | -10,266,000USD | -6,000,000USD | — | -5,931,000USD | — | — | — |
| Investments | — | -4,558,000USD | -1,051,000USD | -2,823,000USD | -1,874,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Advanced Materials | 205,000 | USD | 0001999371-26-010555 |
| Q1 2026Quarterly · 2026-03-31 | Product | Consumer Products | 10,027,000 | USD | 0001999371-26-010555 |
| Q1 2026Quarterly · 2026-03-31 | Product | Personal Care Ingredients | 2,725,000 | USD | 0001999371-26-010555 |
| Q4 2025Quarterly · 2025-12-31 | Product | Advanced Materials | 89,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Consumer Products | 10,499,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Personal Care Ingredients | 1,895,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Advanced Materials | 857,000 | USD | 0001999371-26-007345 |
| FY 2025Yearly · 2025-12-31 | Product | Consumer Products | 54,868,000 | USD | 0001999371-26-007345 |
| FY 2025Yearly · 2025-12-31 | Product | Personal Care Ingredients | 6,339,000 | USD | 0001999371-26-007345 |
| Q3 2025Quarterly · 2025-09-30 | Product | Advanced Materials | 270,000 | USD | 0001999371-25-017415 |
| Q3 2025Quarterly · 2025-09-30 | Product | Consumer Products | 13,943,000 | USD | 0001999371-25-017415 |
| Q3 2025Quarterly · 2025-09-30 | Product | Personal Care Ingredients | 384,000 | USD | 0001999371-25-017415 |
| Q2 2025Quarterly · 2025-06-30 | Product | Advanced Materials | 128,000 | USD | 0001999371-25-011366 |
| Q2 2025Quarterly · 2025-06-30 | Product | Consumer Products | 17,544,000 | USD | 0001999371-25-011366 |
| Q2 2025Quarterly · 2025-06-30 | Product | Personal Care Ingredients | 2,687,000 | USD | 0001999371-25-011366 |
| Q1 2025Quarterly · 2025-03-31 | Product | Advanced Materials | 370,000 | USD | 0001999371-26-010555 |
| Q1 2025Quarterly · 2025-03-31 | Product | Consumer Products | 12,882,000 | USD | 0001999371-26-010555 |
| Q1 2025Quarterly · 2025-03-31 | Product | Personal Care Ingredients | 1,373,000 | USD | 0001999371-26-010555 |
| Q4 2024Quarterly · 2024-12-31 | Product | Advanced Materials | 237,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Consumer Products | 11,469,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Personal Care Ingredients | 861,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Advanced Materials | 1,147,000 | USD | 0001999371-26-007345 |
| FY 2024Yearly · 2024-12-31 | Product | Consumer Products | 44,373,000 | USD | 0001999371-26-007345 |
| FY 2024Yearly · 2024-12-31 | Product | Personal Care Ingredients | 6,827,000 | USD | 0001999371-26-007345 |
| Q3 2024Quarterly · 2024-09-30 | Product | Advanced Materials | 421,000 | USD | 0001999371-25-017415 |
| Q3 2024Quarterly · 2024-09-30 | Product | Consumer Products | 13,600,000 | USD | 0001999371-25-017415 |
| Q3 2024Quarterly · 2024-09-30 | Product | Personal Care Ingredients | 2,845,000 | USD | 0001999371-25-017415 |
| Q2 2024Quarterly · 2024-06-30 | Product | Advanced Materials | 101,000 | USD | 0001999371-25-011366 |
| Q2 2024Quarterly · 2024-06-30 | Product | Consumer Products | 11,200,000 | USD | 0001999371-25-011366 |
| Q2 2024Quarterly · 2024-06-30 | Product | Personal Care Ingredients | 1,745,000 | USD | 0001999371-25-011366 |
| FY 2023Yearly · 2023-12-31 | Product | Advanced Materials | 2,809,000 | USD | 0001999371-25-003471 |
| FY 2023Yearly · 2023-12-31 | Product | Consumer Products | 25,211,000 | USD | 0001999371-25-003471 |
| FY 2023Yearly · 2023-12-31 | Product | Personal Care Ingredients | 9,277,000 | USD | 0001999371-25-003471 |
| FY 2022Yearly · 2022-12-31 | Product | Advanced Materials | 3,085,000 | USD | 0001999371-24-004138 |
| FY 2022Yearly · 2022-12-31 | Product | Personal Care Ingredients | 11,121,000 | USD | 0001999371-24-004138 |
| FY 2022Yearly · 2022-12-31 | Product | Solesence | 23,111,000 | USD | 0001999371-24-004138 |
| FY 2021Yearly · 2021-12-31 | Product | Advanced Materials | 3,561,000 | USD | 0001839882-23-007887 |
| FY 2021Yearly · 2021-12-31 | Product | Personal Care Ingredients | 7,739,000 | USD | 0001839882-23-007887 |
| FY 2021Yearly · 2021-12-31 | Product | Solesence | 18,175,000 | USD | 0001839882-23-007887 |
| FY 2020Yearly · 2020-12-31 | Product | Advanced Materials | 5,536,000 | USD | 0001387131-22-004477 |
| FY 2020Yearly · 2020-12-31 | Product | Personal Care Ingredients | 6,737,000 | USD | 0001387131-22-004477 |
| FY 2020Yearly · 2020-12-31 | Product | Solesence | 4,850,000 | USD | 0001387131-22-004477 |
| FY 2019Yearly · 2019-12-31 | Product | Advanced Materials | 2,733,000 | USD | 0001387131-21-003916 |
| FY 2019Yearly · 2019-12-31 | Product | Manufactured Product Other | 7,919,000 | USD | 0001387131-21-003916 |
| FY 2019Yearly · 2019-12-31 | Product | Solesence | 1,857,000 | USD | 0001387131-21-003916 |
| FY 2018Yearly · 2018-12-31 | Product | Advanced Materials | 2,253,000 | USD | 0001387131-20-003364 |
| FY 2018Yearly · 2018-12-31 | Product | Manufactured Product Other | 10,573,000 | USD | 0001387131-20-003364 |
| FY 2018Yearly · 2018-12-31 | Product | Solesence | 1,367,000 | USD | 0001387131-20-003364 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.